The aim of the SIG is to create an environment where academics, clinicians and businesses can meet, learn from each other and explore possible collaborations that will ultimately lead to commercialisation of innovative products and services within the healthcare remit.
Alan, who was recently honoured in the ‘Logistics 100’ as one of the UK logistics industry’s most influential players by the SHD Logistics Magazine, along with the Derby Evening Telegraphs ‘Derby Inspirational 250’, was identified by members of the SIG as an ideal candidate to take the group forward.
Alan commented;
‘It’s really exciting to be offered the opportunity to lead and develop the Supply Chain Special Interest Group, and I look forward to creating many synergies and enhancing capabilities across the East Midlands. Fresh Pharma have been members of Medilink EM for two years now, and were proud to be selected as finalists in the Medilink East Midlands ‘Collaboration with the NHS’ category of the Business Awards for 2016.’
Prior to setting up Fresh Logistics in 2008 and Fresh Pharma (a branch of Fresh Logistics dedicated to the life sciences) in 2015, Alan had worked in the supply chain industry for many household company names, in roles from Logistics Manger up to Site Director. The Fresh Logistics Group was started with seedling finance of £6,000. Today, the company has 40 of the highest specification temperature controlled vehicles, 3 temperature controlled sites nationally and is expecting turnover of £3,000,000 this financial year.
The Supply Chain Special Interest Group events are free to attend thanks to support from the European Regional Development Fund and are delivered by Medilink East Midlands as part of the INSTILS programme – a project part-funded by the European Regional Development Fund.
To find out more about Fresh Pharma, please click here.
Editors Notes:
About INSTILS: Inspiring Networking to Stimulate Technology Innovation in Life Sciences
INSTILS is an initiative, which is part-financed by the European Regional Development Fund (ERDF) and delivered by Medilink East Midlands. The key aims of INSTILS are to deliver high quality innovation support, work alongside emerging Life Science technologies, enable transfer of technologies between sectors and increase Research & Development investment.
About the European Regional Development Fund
The project is receiving up to £2,482,417 of funding from the England European Regional Development Fund as part of the European Structural and Investment Funds Growth Programme 2014-2020. The Department for Communities and Local Government (and in London the intermediate body Greater London Authority) is the Managing Authority for European Regional Development Fund. Established by the European Union, the European Regional Development Fund helps local areas stimulate their economic development by investing in projects which will support innovation, businesses, create jobs and local community regenerations. For more information visit https://www.gov.uk/european-growth-funding.
About Medilink East Midlands
Medilink East Midlands is the region’s life science industry association, whose aim is to help companies establish, develop and grow. Its network of more than 4,400 contacts in over 1000 organisations represents all aspects of the sector, including private and public institutions; from multinationals to high potential start-ups, as well as the NHS and universities.
Medilink East Midlands is a founding member of Medilink UK; a national network supporting over 3,000 companies across the entire UK. Medilink provides specialist support to boost the region’s economic output from life sciences by overcoming barriers to growth. Medilink’s highly knowledgeable team is a proven and trusted source of expert assistance.
